Cellebrite DI Ltd. CLBT · NASDAQ
$11.79 +2.52% (+$0.29)
Summary
66 / 100 · Bulios Score
What speaks for it
- It holds more cash than debt: $141.3M against $23.2M.
- Out of every 100 USD of revenue, 27 USD is left as free cash.
- Revenue grew by 21% a year over the last 3 years.
- Analysts expect revenue to grow by 17% this fiscal year.
What to watch
- Earnings per share fell by 19% a year over the last 3 years.
- It earns only 6.9 USD a year on every 100 USD of invested capital.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Fairly pricedBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 50.4 USD for 1 USD of yearly profit. Over the last five years it was 27.6 USD on average.
Valuation in detailIs it growing?
SlowlyRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 20% a year over 5 years. Over the last 3 years it grew by 21% a year. For the next fiscal year analysts expect revenue to grow by 17%. Earnings per share fell by 19% a year over the last 3 years.
Growth in detailDoes it make money?
Very wellWhere 100 USD of revenue goes
- Cost of sales 17 USD
- Research and development 25 USD
- Sales and administration 47 USD
- Taxes and other -0.4 USD
- Net profit 11 USD
Net profit, industry median (Software - Infrastructure) 8.7 USD
Out of every 100 USD of revenue, 11 USD is left as net profit.
Profitability in detailIs it financially healthy?
YesIt could repay all its debt from a single year of free cash flow. It holds more cash than debt.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 9
- Hold 0
- Sell 0
Today's price within the analysts' price targets
The average target of $14.13 is 20% above today's price. 100% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Subscription Services 72%
- Term-Licenses 21%
- Professional Services 6.7%
By region
- Americas 54%
- EMEA 34%
- Asia Pacific 12%
Subscription Services brings in 72% of revenue.
Segments in detail